Unlock New Possibilities with PsychoGenics’ Special Offer!
We’re excited to introduce more clients to our AI-enabled platforms through an exclusive promotion, available throughout the year. Offer Details:...
Unlock New Possibilities with PsychoGenics’ Special Offer!
We’re excited to introduce more clients to our AI-enabled platforms through an exclusive promotion! Offer Details: About SmartCube® and eCube®...
Preclinical EEG Services
Electroencephalography (EEG) offers a valuable electrophysiological biomarker. The inherent properties of the recorded signals in rodents and humans are translational,...
Characterization of a Rat Model of CMT2A
The below data was made possible by CMTA, the Charcot-Marie-Tooth Association. Charcot-Marie-Tooth (CMT) disorders are a family of related disorders that...
Characterization of a Mouse and Rat Model of CMT1A
The below data was made possible by CMTA, the Charcot-Marie-Tooth Association. Charcot-Marie Tooth (CMT) disorders are a family of related disorders...
Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder.
doi: 10.1371/journal.pone.0134572. eCollection 2015. Brunner D., Kabitzke P., He D., Cox K., Thiede L., Hanania T., He D., Sabath E., Alexandrov...
Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington’s disease: zQ175
Menalled L, Kudwa A, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio B, McConnell K,...
Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration,
Brunner, D., Balci, F., and Ludvig, E. A. Behav Processes 2011 89, 187-195
Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms.
Steven L Roberts, Filippov I.; Alexandrov V.; Hanania T.; Brunner D. Frontiers in Neuropharmacology.
Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
Paterson, N. E.; Ricciardi, J.; Wetzler, C.; Hanania, T. Neurosci Res 2011, 69, 41-50.